APO Research
Talk to an analyst

APO RESEARCH · REPORT

Oral Anticoagulants

Compare research editions
View pricing & licenses

Selected research

Industry Growth & Trends

Global Oral Anticoagulants Industry Growth and Trends Forecast to 2032

20 December 2025117 pages

Choose your research edition.

Industry ResearchOral Anticoagulants Industry Research Report 2026138 pages · $2,950 USDIndustry Growth & TrendsGlobal Oral Anticoagulants Industry Growth and Trends Forecast to 2032117 pages · $3,450 USDMarket StructureGlobal Oral Anticoagulants Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032193 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Oral Anticoagulants Market Outlook and Growth Opportunities 2026208 pages · $4,250 USDMarket Analysis & ForecastGlobal Oral Anticoagulants Market Analysis and Forecast 2026-2032202 pages · $4,950 USD

Market perspective

The global Oral Anticoagulants market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The North America market for Oral Anticoagulants is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.

The Europe market for Oral Anticoagulants is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for Oral Anticoagulants is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of Oral Anticoagulants include Eisai, Sanofi, Johnson & Johnson, GSK, Daiichi Sankyo, Bayer, AstraZeneca, Perosphere and Ockham Biotech, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Scope

This report provides a structured, data-driven view of the global Oral Anticoagulants market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.

The Oral Anticoagulants market size, estimates, and forecasts are presented in terms of sales volume (k units) and revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global Oral Anticoagulants market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to Oral Anticoagulants.

Key Companies & Market Share Insights

This section analyzes the strategies and performance of leading manufacturers in the global Oral Anticoagulants market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue, price, and sales volume data by manufacturer for 2020-2025, enabling benchmarking of scale, pricing, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.

Oral Anticoagulants Market by Company

Eisai

Sanofi

Johnson & Johnson

GSK

Daiichi Sankyo

Bayer

AstraZeneca

Perosphere

Ockham Biotech

Marathon Pharmaceuticals

CSL Behring

Cosmo Pharmaceuticals

Cellceutix

Bristol-Myers Squibb

Boehringer Ingelheim

Aspen

Armatheon

Oral Anticoagulants Segment by Type

Direct Thrombin Inhibitors

Direct Factor Xa Inhibitors

Oral Anticoagulants Segment by Application

Hemodialysis

Deep Vein Thrombosis (DVT)

Acute Coronary Syndrome

Pulmonary Embolism

Others

Oral Anticoagulants Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Oral Anticoagulants market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Oral Anticoagulants and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Oral Anticoagulants.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the study scope of this report, executive summary of market segments by type, market size segments for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Oral Anticoagulants manufacturers competitive landscape, price, sales, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Sales, revenue of Oral Anticoagulants in regional level. It provides a quantitative analysis of the market size and development potential of each region and introduces the future development prospects, and market space in the world.

Chapter 5: Introduces market segments by application, market size segment for North America, Europe, Asia Pacific, South America, Middle East & Africa.

Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, sales and revenue by country.

Chapter 12: Analysis of industrial chain, key raw materials, manufacturing cost, and market dynamics.

Chapter 13: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Major Company of Direct Thrombin Inhibitors Table 2. Major Company of Direct Factor Xa Inhibitors Table 3. Global Oral Anticoagulants Sales by Type (2021 VS 2025 VS 2032) & (US$ Million) Table 4. Global Oral Anticoagulants Sales by Type (2021-2026) & (k units) Table 5. Global Oral Anticoagulants Sales Market Share in Volume by Type (2021-2026) Table 6. Global Oral Anticoagulants Sales by Type (2021-2026) & (US$ Million) Table 7. Global Oral Anticoagulants Sales Market Share in Value by Type (2021-2026) Table 8. Global Oral Anticoagulants Price by Type (2021-2026) & (US$/unit) Table 9. Global Oral Anticoagulants Sales by Type (2027-2032) & (k units) Table 10. Global Oral Anticoagulants Sales Market Share in Volume by Type (2027-2032) Table 11. Global Oral Anticoagulants Sales by Type (2027-2032) & (US$ Million) Table 12. Global Oral Anticoagulants Sales Market Share in Value by Type (2027-2032) Table 13. Global Oral Anticoagulants Price by Type (2027-2032) & (US$/unit) Table 14. North America Oral Anticoagulants Sales by Type (2021-2026) & (k units) Table 15. North America Oral Anticoagulants Sales by Type (2021-2026) & (US$ Million) Table 16. Europe Oral Anticoagulants Sales by Type (2021-2026) & (k units) Table 17. Europe Oral Anticoagulants Sales by Type (2021-2026) & (US$ Million) Table 18. Asia-Pacific Oral Anticoagulants Sales by Type (2021-2026) & (k units) Table 19. Asia-Pacific Oral Anticoagulants Sales by Type (2021-2026) & (US$ Million) Table 20. Latin America Oral Anticoagulants Sales by Type (2021-2026) & (k units) Table 21. Latin America Oral Anticoagulants Sales by Type (2021-2026) & (US$ Million) Table 22. Middle East and Africa Oral Anticoagulants Sales by Type (2021-2026) & (k units) Table 23. Middle East and Africa Oral Anticoagulants Sales by Type (2021-2026) & (US$ Million) Table 24. Oral Anticoagulants Industry Trends Table 25. Oral Anticoagulants Industry Drivers Table 26. Oral Anticoagulants Industry Opportunities and Challenges Table 27. Oral Anticoagulants Industry Restraints Table 28. Global Oral Anticoagulants Sales Revenue by Company (US$ Million) & (2021-2026) Table 29. Global Oral Anticoagulants Revenue Market Share by Company (2021-2026) Table 30. Global Oral Anticoagulants Sales by Company (2021-2026) & (k units) Table 31. Global Oral Anticoagulants Sales Share by Company (2021-2026) Table 32. Global Oral Anticoagulants Market Price by Company (2021-2026) & (US$/unit) Table 33. Global Oral Anticoagulants Industry Company Ranking, 2024 VS 2025 VS 2026 Table 34. Global Oral Anticoagulants Major Company Production Sites and Headquarters Table 35. Global Oral Anticoagulants Company, Product Type & Application Table 36. Global Oral Anticoagulants Company Establishment Date Table 37. Global Company Market Concentration Ratio (CR5 and HHI) Table 38. Global Oral Anticoagulants by Company Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 39. Global Oral Anticoagulants Market Size Comparison by Region (US$ Million): 2021 VS 2025 VS 2032 Table 40. Global Oral Anticoagulants Sales by Region (2021-2026) & (k units) Table 41. Global Oral Anticoagulants Sales Market Share in Volume by Region (2021-2026) Table 42. Global Oral Anticoagulants Sales by Region (2021-2026) & (US$ Million) Table 43. Global Oral Anticoagulants Sales Market Share in Value by Region (2021-2026) Table 44. Global Oral Anticoagulants Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 45. Global Oral Anticoagulants Sales by Region (2027-2032) & (k units) Table 46. Global Oral Anticoagulants Sales Market Share in Volume by Region (2027-2032) Table 47. Global Oral Anticoagulants Sales by Region (2027-2032) & (US$ Million) Table 48. Global Oral Anticoagulants Sales Market Share in Value by Region (2027-2032) Table 49. Global Oral Anticoagulants Sales (k units), Value (US$ Million), Price (US$/unit) and Gross Margin (2027-2032) Table 50. Global Oral Anticoagulants Sales by Application (2021 VS 2025 VS 2032) & (US$ Million) Table 51. Global Oral Anticoagulants Sales by Application (2021-2026) & (k units) Table 52. Global Oral Anticoagulants Sales Market Share in Volume by Application (2021-2026) Table 53. Global Oral Anticoagulants Sales by Application (2021-2026) & (US$ Million) Table 54. Global Oral Anticoagulants Sales Market Share in Value by Application (2021-2026) Table 55. Global Oral Anticoagulants Price by Application (2021-2026) & (US$/unit) Table 56. Global Oral Anticoagulants Sales by Application (2027-2032) & (k units) Table 57. Global Oral Anticoagulants Sales Market Share in Volume by Application (2027-2032) Table 58. Global Oral Anticoagulants Sales by Application (2027-2032) & (US$ Million) Table 59. Global Oral Anticoagulants Sales Market Share in Value by Application (2027-2032) Table 60. Global Oral Anticoagulants Price by Application (2027-2032) & (US$/unit) Table 61. North America Oral Anticoagulants Sales by Application (2021-2026) & (k units) Table 62. North America Oral Anticoagulants Sales by Application (2021-2026) & (US$ Million) Table 63. Europe Oral Anticoagulants Sales by Application (2021-2026) & (k units) Table 64. Europe Oral Anticoagulants Sales by Application (2021-2026) & (US$ Million) Table 65. Asia-Pacific Oral Anticoagulants Sales by Application (2021-2026) & (k units) Table 66. Asia-Pacific Oral Anticoagulants Sales by Application (2021-2026) & (US$ Million) Table 67. Latin America Oral Anticoagulants Sales by Application (2021-2026) & (k units) Table 68. Latin America Oral Anticoagulants Sales by Application (2021-2026) & (US$ Million) Table 69. Middle East and Africa Oral Anticoagulants Sales by Application (2021-2026) & (k units) Table 70. Middle East and Africa Oral Anticoagulants Sales by Application (2021-2026) & (US$ Million) Table 71. Eisai Company Information Table 72. Eisai Business Overview Table 73. Eisai Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Eisai Oral Anticoagulants Product Portfolio Table 75. Eisai Recent Development Table 76. Sanofi Company Information Table 77. Sanofi Business Overview Table 78. Sanofi Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Sanofi Oral Anticoagulants Product Portfolio Table 80. Sanofi Recent Development Table 81. Johnson & Johnson Company Information Table 82. Johnson & Johnson Business Overview Table 83. Johnson & Johnson Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Johnson & Johnson Oral Anticoagulants Product Portfolio Table 85. Johnson & Johnson Recent Development Table 86. GSK Company Information Table 87. GSK Business Overview Table 88. GSK Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. GSK Oral Anticoagulants Product Portfolio Table 90. GSK Recent Development Table 91. Daiichi Sankyo Company Information Table 92. Daiichi Sankyo Business Overview Table 93. Daiichi Sankyo Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Daiichi Sankyo Oral Anticoagulants Product Portfolio Table 95. Daiichi Sankyo Recent Development Table 96. Bayer Company Information Table 97. Bayer Business Overview Table 98. Bayer Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Bayer Oral Anticoagulants Product Portfolio Table 100. Bayer Recent Development Table 101. AstraZeneca Company Information Table 102. AstraZeneca Business Overview Table 103. AstraZeneca Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 104. AstraZeneca Oral Anticoagulants Product Portfolio Table 105. AstraZeneca Recent Development Table 106. Perosphere Company Information Table 107. Perosphere Business Overview Table 108. Perosphere Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 109. Perosphere Oral Anticoagulants Product Portfolio Table 110. Perosphere Recent Development Table 111. Ockham Biotech Company Information Table 112. Ockham Biotech Business Overview Table 113. Ockham Biotech Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 114. Ockham Biotech Oral Anticoagulants Product Portfolio Table 115. Ockham Biotech Recent Development Table 116. Marathon Pharmaceuticals Company Information Table 117. Marathon Pharmaceuticals Business Overview Table 118. Marathon Pharmaceuticals Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 119. Marathon Pharmaceuticals Oral Anticoagulants Product Portfolio Table 120. Marathon Pharmaceuticals Recent Development Table 121. CSL Behring Company Information Table 122. CSL Behring Business Overview Table 123. CSL Behring Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 124. CSL Behring Oral Anticoagulants Product Portfolio Table 125. CSL Behring Recent Development Table 126. Cosmo Pharmaceuticals Company Information Table 127. Cosmo Pharmaceuticals Business Overview Table 128. Cosmo Pharmaceuticals Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 129. Cosmo Pharmaceuticals Oral Anticoagulants Product Portfolio Table 130. Cosmo Pharmaceuticals Recent Development Table 131. Cellceutix Company Information Table 132. Cellceutix Business Overview Table 133. Cellceutix Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 134. Cellceutix Oral Anticoagulants Product Portfolio Table 135. Cellceutix Recent Development Table 136. Bristol-Myers Squibb Company Information Table 137. Bristol-Myers Squibb Business Overview Table 138. Bristol-Myers Squibb Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 139. Bristol-Myers Squibb Oral Anticoagulants Product Portfolio Table 140. Bristol-Myers Squibb Recent Development Table 141. Boehringer Ingelheim Company Information Table 142. Boehringer Ingelheim Business Overview Table 143. Boehringer Ingelheim Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 144. Boehringer Ingelheim Oral Anticoagulants Product Portfolio Table 145. Boehringer Ingelheim Recent Development Table 146. Aspen Company Information Table 147. Aspen Business Overview Table 148. Aspen Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 149. Aspen Oral Anticoagulants Product Portfolio Table 150. Aspen Recent Development Table 151. Armatheon Company Information Table 152. Armatheon Business Overview Table 153. Armatheon Oral Anticoagulants Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 154. Armatheon Oral Anticoagulants Product Portfolio Table 155. Armatheon Recent Development Table 156. North America Oral Anticoagulants Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 157. North America Oral Anticoagulants Sales by Country (2021-2026) & (k units) Table 158. North America Oral Anticoagulants Sales Market Share by Country (2021-2026) Table 159. North America Oral Anticoagulants Sales Forecast by Country (2027-2032) & (k units) Table 160. North America Oral Anticoagulants Sales Market Share Forecast by Country (2027-2032) Table 161. North America Oral Anticoagulants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 162. North America Oral Anticoagulants Market Size by Country (2021-2026) & (US$ Million) Table 163. North America Oral Anticoagulants Market Share by Country (2021-2026) Table 164. North America Oral Anticoagulants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 165. North America Oral Anticoagulants Market Share Forecast by Country (2027-2032) Table 166. Europe Oral Anticoagulants Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 167. Europe Oral Anticoagulants Sales by Country (2021-2026) & (k units) Table 168. Europe Oral Anticoagulants Sales Market Share by Country (2021-2026) Table 169. Europe Oral Anticoagulants Sales Forecast by Country (2027-2032) & (k units) Table 170. Europe Oral Anticoagulants Sales Market Share Forecast by Country (2027-2032) Table 171. Europe Oral Anticoagulants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 172. Europe Oral Anticoagulants Market Size by Country (2021-2026) & (US$ Million) Table 173. Europe Oral Anticoagulants Market Share by Country (2021-2026) Table 174. Europe Oral Anticoagulants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 175. Europe Oral Anticoagulants Market Share Forecast by Country (2027-2032) Table 176. Asia-Pacific Oral Anticoagulants Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 177. Asia-Pacific Oral Anticoagulants Sales by Country (2021-2026) & (k units) Table 178. Asia-Pacific Oral Anticoagulants Sales Market Share by Country (2021-2026) Table 179. Asia-Pacific Oral Anticoagulants Sales Forecast by Country (2027-2032) & (k units) Table 180. Asia-Pacific Oral Anticoagulants Sales Market Share Forecast by Country (2027-2032) Table 181. Asia-Pacific Oral Anticoagulants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 182. Asia-Pacific Oral Anticoagulants Market Size by Country (2021-2026) & (US$ Million) Table 183. Asia-Pacific Oral Anticoagulants Market Share by Country (2021-2026) Table 184. Asia-Pacific Oral Anticoagulants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 185. Asia-Pacific Oral Anticoagulants Market Share Forecast by Country (2027-2032) Table 186. Latin America Oral Anticoagulants Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 187. Latin America Oral Anticoagulants Sales by Country (2021-2026) & (k units) Table 188. Latin America Oral Anticoagulants Sales Market Share by Country (2021-2026) Table 189. Latin America Oral Anticoagulants Sales Forecast by Country (2027-2032) & (k units) Table 190. Latin America Oral Anticoagulants Sales Market Share Forecast by Country (2027-2032) Table 191. Latin America Oral Anticoagulants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 192. Latin America Oral Anticoagulants Market Size by Country (2021-2026) & (US$ Million) Table 193. Latin America Oral Anticoagulants Market Share by Country (2021-2026) Table 194. Latin America Oral Anticoagulants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 195. Latin America Oral Anticoagulants Market Share Forecast by Country (2027-2032) Table 196. Middle East and Africa Oral Anticoagulants Market Size Growth Rate (CAGR) by Country (k units): 2021 VS 2025 VS 2032 Table 197. Middle East and Africa Oral Anticoagulants Sales by Country (2021-2026) & (k units) Table 198. Middle East and Africa Oral Anticoagulants Sales Market Share by Country (2021-2026) Table 199. Middle East and Africa Oral Anticoagulants Sales Forecast by Country (2027-2032) & (k units) Table 200. Middle East and Africa Oral Anticoagulants Sales Market Share Forecast by Country (2027-2032) Table 201. Middle East and Africa Oral Anticoagulants Market Size Growth Rate (CAGR) by Country (US$ Million): 2021 VS 2025 VS 2032 Table 202. Middle East and Africa Oral Anticoagulants Market Size by Country (2021-2026) & (US$ Million) Table 203. Middle East and Africa Oral Anticoagulants Market Share by Country (2021-2026) Table 204. Middle East and Africa Oral Anticoagulants Market Size Forecast by Country (2027-2032) & (US$ Million) Table 205. Middle East and Africa Oral Anticoagulants Market Share Forecast by Country (2027-2032) Table 206. Key Raw Materials Table 207. Raw Materials Key Suppliers Table 208. Oral Anticoagulants Distributors List Table 209. Oral Anticoagulants Customers List Table 210. Research Programs/Design for This Report Table 211. Authors List of This Report Table 212. Secondary Sources Table 213. Primary Sources List of Figures Figure 1. Oral Anticoagulants Image Figure 2. Global Oral Anticoagulants Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Oral Anticoagulants Market Size (2021-2032) & (US$ Million) Figure 4. Global Oral Anticoagulants Sales (2021-2032) & (k units) Figure 5. Direct Thrombin Inhibitors Image Figure 6. Global Direct Thrombin Inhibitors Sales YoY Growth (2021-2032) & (k units) Figure 7. Direct Factor Xa Inhibitors Image Figure 8. Global Direct Factor Xa Inhibitors Sales YoY Growth (2021-2032) & (k units) Figure 9. Global Oral Anticoagulants Market Size Overview by Type (2021-2032) & (US$ Million) Figure 10. Global Oral Anticoagulants Market Share by Type 2025 VS 2032 Figure 11. North America Oral Anticoagulants Sales Market Share in Volume by Type in 2025 Figure 12. North America Oral Anticoagulants Sales Market Share in Value by Type in 2025 Figure 13. Europe Oral Anticoagulants Sales Market Share in Volume by Type in 2025 Figure 14. Europe Oral Anticoagulants Sales Market Share in Value by Type in 2025 Figure 15. Asia-Pacific Oral Anticoagulants Sales Market Share in Volume by Type in 2025 Figure 16. Asia-Pacific Oral Anticoagulants Sales Market Share in Value by Type in 2025 Figure 17. Latin America Oral Anticoagulants Sales Market Share in Volume by Type in 2025 Figure 18. Latin America Oral Anticoagulants Sales Market Share in Value by Type in 2025 Figure 19. Middle East and Africa Oral Anticoagulants Sales Market Share in Volume by Type in 2025 Figure 20. Middle East and Africa Oral Anticoagulants Sales Market Share in Value by Type in 2025 Figure 21. Global Top 5 and 10 Oral Anticoagulants Players Market Share by Revenue in 2025 Figure 22. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 23. Hemodialysis Image Figure 24. Global Hemodialysis Sales YoY Growth (2021-2032) & (k units) Figure 25. Deep Vein Thrombosis (DVT) Image Figure 26. Global Deep Vein Thrombosis (DVT) Sales YoY Growth (2021-2032) & (k units) Figure 27. Acute Coronary Syndrome Image Figure 28. Global Acute Coronary Syndrome Sales YoY Growth (2021-2032) & (k units) Figure 29. Pulmonary Embolism Image Figure 30. Global Pulmonary Embolism Sales YoY Growth (2021-2032) & (k units) Figure 31. Others Image Figure 32. Global Others Sales YoY Growth (2021-2032) & (k units) Figure 33. Global Oral Anticoagulants Market Size Overview by Application (2021-2032) & (US$ Million) Figure 34. Global Oral Anticoagulants Market Share by Application 2025 VS 2032 Figure 35. North America Oral Anticoagulants Sales Market Share in Volume by Application in 2025 Figure 36. North America Oral Anticoagulants Sales Market Share in Value by Application in 2025 Figure 37. Europe Oral Anticoagulants Sales Market Share in Volume by Application in 2025 Figure 38. Europe Oral Anticoagulants Sales Market Share in Value by Application in 2025 Figure 39. Asia-Pacific Oral Anticoagulants Sales Market Share in Volume by Application in 2025 Figure 40. Asia-Pacific Oral Anticoagulants Sales Market Share in Value by Application in 2025 Figure 41. Latin America Oral Anticoagulants Sales Market Share in Volume by Application in 2025 Figure 42. Latin America Oral Anticoagulants Sales Market Share in Value by Application in 2025 Figure 43. Middle East and Africa Oral Anticoagulants Sales Market Share in Volume by Application in 2025 Figure 44. Middle East and Africa Oral Anticoagulants Sales Market Share in Value by Application in 2025 Figure 45. North America Oral Anticoagulants Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 46. North America Oral Anticoagulants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 47. North America Oral Anticoagulants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 48. North America Oral Anticoagulants Market Share by Country: 2021 VS 2025 VS 2032 Figure 49. Europe Oral Anticoagulants Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 50. Europe Oral Anticoagulants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 51. Europe Oral Anticoagulants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 52. Europe Oral Anticoagulants Market Share by Country: 2021 VS 2025 VS 2032 Figure 53. Asia-Pacific Oral Anticoagulants Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 54. Asia-Pacific Oral Anticoagulants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 55. Asia-Pacific Oral Anticoagulants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 56. Asia-Pacific Oral Anticoagulants Market Share by Country: 2021 VS 2025 VS 2032 Figure 57. Latin America Oral Anticoagulants Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 58. Latin America Oral Anticoagulants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 59. Latin America Oral Anticoagulants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 60. Latin America Oral Anticoagulants Market Share by Country: 2021 VS 2025 VS 2032 Figure 61. Middle East and Africa Oral Anticoagulants Sales by Country: 2021 VS 2025 VS 2032 (k units) Figure 62. Middle East and Africa Oral Anticoagulants Sales Share by Country: 2021 VS 2025 VS 2032 Figure 63. Middle East and Africa Oral Anticoagulants Market Size by Country: 2021 VS 2025 VS 2032 (US$ Million) Figure 64. Middle East and Africa Oral Anticoagulants Market Share by Country: 2021 VS 2025 VS 2032 Figure 65. Oral Anticoagulants Value Chain Figure 66. Key Raw Materials Price Figure 67. Manufacturing Cost Structure Figure 68. Oral Anticoagulants Production Mode & Process Figure 69. Direct Comparison with Distribution Share Figure 70. Distributors Profiles Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Direct Thrombin Inhibitors
  • Direct Factor Xa Inhibitors
Applications
  • Hemodialysis
  • Deep Vein Thrombosis (DVT)
  • Acute Coronary Syndrome
  • Pulmonary Embolism
  • Others
Companies covered
  • Eisai
  • Sanofi
  • Johnson & Johnson
  • GSK
  • Daiichi Sankyo
  • Bayer
  • AstraZeneca
  • Perosphere
  • Ockham Biotech
  • Marathon Pharmaceuticals
  • CSL Behring
  • Cosmo Pharmaceuticals
  • Cellceutix
  • Bristol-Myers Squibb
  • Boehringer Ingelheim
  • Aspen
  • Armatheon

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Global Market Growth Prospects
  3. 1.2.1 Global Oral Anticoagulants Market Size Estimates and Forecasts (2021-2032)
  4. 1.2.2 Global Oral Anticoagulants Sales Estimates and Forecasts (2021-2032)
  5. 1.3 Oral Anticoagulants Market by Type
  6. 1.3.1 Direct Thrombin Inhibitors
  7. 1.3.2 Direct Factor Xa Inhibitors
  8. 1.4 Global Oral Anticoagulants Market Size by Type
  9. 1.4.1 Global Oral Anticoagulants Market Size Overview by Type (2021-2032)
  10. 1.4.2 Global Oral Anticoagulants Historic Market Size Review by Type (2021-2026)
  11. 1.4.3 Global Oral Anticoagulants Forecasted Market Size by Type (2027-2032)
  12. 1.5 Key Regions Market Size by Type
  13. 1.5.1 North America Oral Anticoagulants Sales Breakdown by Type (2021-2026)
  14. 1.5.2 Europe Oral Anticoagulants Sales Breakdown by Type (2021-2026)
  15. 1.5.3 Asia-Pacific Oral Anticoagulants Sales Breakdown by Type (2021-2026)
  16. 1.5.4 South America Oral Anticoagulants Sales Breakdown by Type (2021-2026)
  17. 1.5.5 Middle East and Africa Oral Anticoagulants Sales Breakdown by Type (2021-2026)
2 Global Market Dynamics
  1. 2.1 Oral Anticoagulants Industry Trends
  2. 2.2 Oral Anticoagulants Industry Drivers
  3. 2.3 Oral Anticoagulants Industry Opportunities and Challenges
  4. 2.4 Oral Anticoagulants Industry Restraints
3 Market Competitive Landscape by Company
  1. 3.1 Global Top Players by Oral Anticoagulants Revenue (2021-2026)
  2. 3.2 Global Top Players by Oral Anticoagulants Sales (2021-2026)
  3. 3.3 Global Top Players by Oral Anticoagulants Price (2021-2026)
  4. 3.4 Global Oral Anticoagulants Industry Company Ranking, 2024 VS 2025 VS 2026
  5. 3.5 Global Oral Anticoagulants Major Company Production Sites & Headquarters
  6. 3.6 Global Oral Anticoagulants Company, Product Type & Application
  7. 3.7 Global Oral Anticoagulants Company Establishment Date
  8. 3.8 Market Competitive Analysis
  9. 3.8.1 Global Oral Anticoagulants Market CR5 and HHI
  10. 3.8.2 Global Top 5 and 10 Oral Anticoagulants Players Market Share by Revenue in 2025
  11. 3.8.3 2025 Oral Anticoagulants Tier 1, Tier 2, and Tier 3
4 Oral Anticoagulants Regional Status and Outlook
  1. 4.1 Global Oral Anticoagulants Market Size and CAGR by Region: 2021 VS 2025 VS 2032
  2. 4.2 Global Oral Anticoagulants Historic Market Size by Region
  3. 4.2.1 Global Oral Anticoagulants Sales in Volume by Region (2021-2026)
  4. 4.2.2 Global Oral Anticoagulants Sales in Value by Region (2021-2026)
  5. 4.2.3 Global Oral Anticoagulants Sales (Volume & Value), Price and Gross Margin (2021-2026)
  6. 4.3 Global Oral Anticoagulants Forecasted Market Size by Region
  7. 4.3.1 Global Oral Anticoagulants Sales in Volume by Region (2027-2032)
  8. 4.3.2 Global Oral Anticoagulants Sales in Value by Region (2027-2032)
  9. 4.3.3 Global Oral Anticoagulants Sales (Volume & Value), Price and Gross Margin (2027-2032)
5 Oral Anticoagulants by Application
  1. 5.1 Oral Anticoagulants Market by Application
  2. 5.1.1 Hemodialysis
  3. 5.1.2 Deep Vein Thrombosis (DVT)
  4. 5.1.3 Acute Coronary Syndrome
  5. 5.1.4 Pulmonary Embolism
  6. 5.1.5 Others
  7. 5.2 Global Oral Anticoagulants Market Size by Application
  8. 5.2.1 Global Oral Anticoagulants Market Size Overview by Application (2021-2032)
  9. 5.2.2 Global Oral Anticoagulants Historic Market Size Review by Application (2021-2026)
  10. 5.2.3 Global Oral Anticoagulants Forecasted Market Size by Application (2027-2032)
  11. 5.3 Key Regions Market Size by Application
  12. 5.3.1 North America Oral Anticoagulants Sales Breakdown by Application (2021-2026)
  13. 5.3.2 Europe Oral Anticoagulants Sales Breakdown by Application (2021-2026)
  14. 5.3.3 Asia-Pacific Oral Anticoagulants Sales Breakdown by Application (2021-2026)
  15. 5.3.4 South America Oral Anticoagulants Sales Breakdown by Application (2021-2026)
  16. 5.3.5 Middle East and Africa Oral Anticoagulants Sales Breakdown by Application (2021-2026)
6 Company Profiles
  1. 6.1 Eisai
  2. 6.1.1 Eisai Company Information
  3. 6.1.2 Eisai Business Overview
  4. 6.1.3 Eisai Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  5. 6.1.4 Eisai Oral Anticoagulants Product Portfolio
  6. 6.1.5 Eisai Recent Developments
  7. 6.2 Sanofi
  8. 6.2.1 Sanofi Company Information
  9. 6.2.2 Sanofi Business Overview
  10. 6.2.3 Sanofi Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  11. 6.2.4 Sanofi Oral Anticoagulants Product Portfolio
  12. 6.2.5 Sanofi Recent Developments
  13. 6.3 Johnson & Johnson
  14. 6.3.1 Johnson & Johnson Company Information
  15. 6.3.2 Johnson & Johnson Business Overview
  16. 6.3.3 Johnson & Johnson Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  17. 6.3.4 Johnson & Johnson Oral Anticoagulants Product Portfolio
  18. 6.3.5 Johnson & Johnson Recent Developments
  19. 6.4 GSK
  20. 6.4.1 GSK Company Information
  21. 6.4.2 GSK Business Overview
  22. 6.4.3 GSK Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  23. 6.4.4 GSK Oral Anticoagulants Product Portfolio
  24. 6.4.5 GSK Recent Developments
  25. 6.5 Daiichi Sankyo
  26. 6.5.1 Daiichi Sankyo Company Information
  27. 6.5.2 Daiichi Sankyo Business Overview
  28. 6.5.3 Daiichi Sankyo Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  29. 6.5.4 Daiichi Sankyo Oral Anticoagulants Product Portfolio
  30. 6.5.5 Daiichi Sankyo Recent Developments
  31. 6.6 Bayer
  32. 6.6.1 Bayer Company Information
  33. 6.6.2 Bayer Business Overview
  34. 6.6.3 Bayer Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  35. 6.6.4 Bayer Oral Anticoagulants Product Portfolio
  36. 6.6.5 Bayer Recent Developments
  37. 6.7 AstraZeneca
  38. 6.7.1 AstraZeneca Company Information
  39. 6.7.2 AstraZeneca Business Overview
  40. 6.7.3 AstraZeneca Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  41. 6.7.4 AstraZeneca Oral Anticoagulants Product Portfolio
  42. 6.7.5 AstraZeneca Recent Developments
  43. 6.8 Perosphere
  44. 6.8.1 Perosphere Company Information
  45. 6.8.2 Perosphere Business Overview
  46. 6.8.3 Perosphere Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  47. 6.8.4 Perosphere Oral Anticoagulants Product Portfolio
  48. 6.8.5 Perosphere Recent Developments
  49. 6.9 Ockham Biotech
  50. 6.9.1 Ockham Biotech Company Information
  51. 6.9.2 Ockham Biotech Business Overview
  52. 6.9.3 Ockham Biotech Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  53. 6.9.4 Ockham Biotech Oral Anticoagulants Product Portfolio
  54. 6.9.5 Ockham Biotech Recent Developments
  55. 6.10 Marathon Pharmaceuticals
  56. 6.10.1 Marathon Pharmaceuticals Company Information
  57. 6.10.2 Marathon Pharmaceuticals Business Overview
  58. 6.10.3 Marathon Pharmaceuticals Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  59. 6.10.4 Marathon Pharmaceuticals Oral Anticoagulants Product Portfolio
  60. 6.10.5 Marathon Pharmaceuticals Recent Developments
  61. 6.11 CSL Behring
  62. 6.11.1 CSL Behring Company Information
  63. 6.11.2 CSL Behring Business Overview
  64. 6.11.3 CSL Behring Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  65. 6.11.4 CSL Behring Oral Anticoagulants Product Portfolio
  66. 6.11.5 CSL Behring Recent Developments
  67. 6.12 Cosmo Pharmaceuticals
  68. 6.12.1 Cosmo Pharmaceuticals Company Information
  69. 6.12.2 Cosmo Pharmaceuticals Business Overview
  70. 6.12.3 Cosmo Pharmaceuticals Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  71. 6.12.4 Cosmo Pharmaceuticals Oral Anticoagulants Product Portfolio
  72. 6.12.5 Cosmo Pharmaceuticals Recent Developments
  73. 6.13 Cellceutix
  74. 6.13.1 Cellceutix Company Information
  75. 6.13.2 Cellceutix Business Overview
  76. 6.13.3 Cellceutix Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  77. 6.13.4 Cellceutix Oral Anticoagulants Product Portfolio
  78. 6.13.5 Cellceutix Recent Developments
  79. 6.14 Bristol-Myers Squibb
  80. 6.14.1 Bristol-Myers Squibb Company Information
  81. 6.14.2 Bristol-Myers Squibb Business Overview
  82. 6.14.3 Bristol-Myers Squibb Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  83. 6.14.4 Bristol-Myers Squibb Oral Anticoagulants Product Portfolio
  84. 6.14.5 Bristol-Myers Squibb Recent Developments
  85. 6.15 Boehringer Ingelheim
  86. 6.15.1 Boehringer Ingelheim Company Information
  87. 6.15.2 Boehringer Ingelheim Business Overview
  88. 6.15.3 Boehringer Ingelheim Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  89. 6.15.4 Boehringer Ingelheim Oral Anticoagulants Product Portfolio
  90. 6.15.5 Boehringer Ingelheim Recent Developments
  91. 6.16 Aspen
  92. 6.16.1 Aspen Company Information
  93. 6.16.2 Aspen Business Overview
  94. 6.16.3 Aspen Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  95. 6.16.4 Aspen Oral Anticoagulants Product Portfolio
  96. 6.16.5 Aspen Recent Developments
  97. 6.17 Armatheon
  98. 6.17.1 Armatheon Company Information
  99. 6.17.2 Armatheon Business Overview
  100. 6.17.3 Armatheon Oral Anticoagulants Sales, Revenue and Gross Margin (2021-2026)
  101. 6.17.4 Armatheon Oral Anticoagulants Product Portfolio
  102. 6.17.5 Armatheon Recent Developments
7 North America by Country
  1. 7.1 North America Oral Anticoagulants Sales by Country
  2. 7.1.1 North America Oral Anticoagulants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 7.1.2 North America Oral Anticoagulants Sales by Country (2021-2026)
  4. 7.1.3 North America Oral Anticoagulants Sales Forecast by Country (2027-2032)
  5. 7.2 North America Oral Anticoagulants Market Size by Country
  6. 7.2.1 North America Oral Anticoagulants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 7.2.2 North America Oral Anticoagulants Market Size by Country (2021-2026)
  8. 7.2.3 North America Oral Anticoagulants Market Size Forecast by Country (2027-2032)
8 Europe by Country
  1. 8.1 Europe Oral Anticoagulants Sales by Country
  2. 8.1.1 Europe Oral Anticoagulants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 8.1.2 Europe Oral Anticoagulants Sales by Country (2021-2026)
  4. 8.1.3 Europe Oral Anticoagulants Sales Forecast by Country (2027-2032)
  5. 8.2 Europe Oral Anticoagulants Market Size by Country
  6. 8.2.1 Europe Oral Anticoagulants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 8.2.2 Europe Oral Anticoagulants Market Size by Country (2021-2026)
  8. 8.2.3 Europe Oral Anticoagulants Market Size Forecast by Country (2027-2032)
9 Asia-Pacific by Country
  1. 9.1 Asia-Pacific Oral Anticoagulants Sales by Country
  2. 9.1.1 Asia-Pacific Oral Anticoagulants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 9.1.2 Asia-Pacific Oral Anticoagulants Sales by Country (2021-2026)
  4. 9.1.3 Asia-Pacific Oral Anticoagulants Sales Forecast by Country (2027-2032)
  5. 9.2 Asia-Pacific Oral Anticoagulants Market Size by Country
  6. 9.2.1 Asia-Pacific Oral Anticoagulants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 9.2.2 Asia-Pacific Oral Anticoagulants Market Size by Country (2021-2026)
  8. 9.2.3 Asia-Pacific Oral Anticoagulants Market Size Forecast by Country (2027-2032)
10 South America by Country
  1. 10.1 South America Oral Anticoagulants Sales by Country
  2. 10.1.1 South America Oral Anticoagulants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 10.1.2 South America Oral Anticoagulants Sales by Country (2021-2026)
  4. 10.1.3 South America Oral Anticoagulants Sales Forecast by Country (2027-2032)
  5. 10.2 South America Oral Anticoagulants Market Size by Country
  6. 10.2.1 South America Oral Anticoagulants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 10.2.2 South America Oral Anticoagulants Market Size by Country (2021-2026)
  8. 10.2.3 South America Oral Anticoagulants Market Size Forecast by Country (2027-2032)
11 Middle East and Africa by Country
  1. 11.1 Middle East and Africa Oral Anticoagulants Sales by Country
  2. 11.1.1 Middle East and Africa Oral Anticoagulants Sales Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  3. 11.1.2 Middle East and Africa Oral Anticoagulants Sales by Country (2021-2026)
  4. 11.1.3 Middle East and Africa Oral Anticoagulants Sales Forecast by Country (2027-2032)
  5. 11.2 Middle East and Africa Oral Anticoagulants Market Size by Country
  6. 11.2.1 Middle East and Africa Oral Anticoagulants Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
  7. 11.2.2 Middle East and Africa Oral Anticoagulants Market Size by Country (2021-2026)
  8. 11.2.3 Middle East and Africa Oral Anticoagulants Market Size Forecast by Country (2027-2032)
12 Value Chain and Sales Channels Analysis
  1. 12.1 Oral Anticoagulants Value Chain Analysis
  2. 12.1.1 Oral Anticoagulants Key Raw Materials
  3. 12.1.2 Key Raw Materials Price
  4. 12.1.3 Raw Materials Key Suppliers
  5. 12.1.4 Manufacturing Cost Structure
  6. 12.1.5 Oral Anticoagulants Production Mode & Process
  7. 12.2 Oral Anticoagulants Sales Channels Analysis
  8. 12.2.1 Direct Comparison with Distribution Share
  9. 12.2.2 Oral Anticoagulants Distributors
  10. 12.2.3 Oral Anticoagulants Customers
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources
    8. 14.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,450USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst